MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Plasma pTau181 and pTau217 Detect Amyloid Co-pathology and Have Specific Cut-offs in Lewy Body Disease

    A. Smith, M. Plastini, N. Ashton, L. Montoliu-Gaya, E. Wilson, B. Arslan, C. Young, J. Winer, M. Shahid-Besanti, H. Vossler, G. Kerchner, B. Cholerton, K. Andreasson, M. Yutsis, V. Henderson, T. Montine, L. Tian, E. Mormino, H. Zetterberg, K. Poston, C. Abdelnour (Stanford, USA)

    Objective: We assess: 1) if the diagnostic accuracy of plasma pTau181 differs from pTau217 in detecting amyloidosis (Aβ) in people with Lewy body disease (LBD)…
  • 2024 International Congress

    Age-associated presbyvestibulopathy is more severely abnormal in PD compared to the older controls

    N. Bohnen, G. Carli, T. Brown, S. David, J. Barr, R. Vangel, T. Johnson, K. Kerber, D. Mccaslin (Ann Arbor, USA)

    Objective: We aim to investigate differences in specific vestibular tests between individuals diagnosed with Parkinson’s Disease (PD) and elderly healthy controls. With consideration for potential…
  • 2024 International Congress

    Risk Factors Of Parkinson’s Disease A Case-Control Study In Tunisian Patients

    S. Sellami, N. Farhat, KS. Moalla, N. Bouattour, S. Daoued, S. Sakka, M. Damak, C. Mhiri (Sfax, Tunisia)

    Objective: To investigate the role of family, environmental and professional factors in Parkinson's disease (PD) development. Background: Parkinson's disease (PD) is a neurological disorder with…
  • 2024 International Congress

    Coat test: a bedside timed test for quantifying motor function in Parkinson’s disease patients.

    C. Holgado, M. Wilken, G. Lopez, M. Merello (Buenos Aires, Argentina)

    Objective: To develop  a bedside  quantitative test for evaluating motor affectation  in patients with Parkinson's Disease. Background: The MDS-UPDRS part III is still the most…
  • 2024 International Congress

    The East London Parkinson Disease Project: updated results from engaging a diverse population in research

    A. Zirra, KC. Dey, T. Haque, E. Camboe, A. Ben-Joseph, J. Kahan, B. Huxford, S. Ganesh, C. Edwards, C. Budu, C. Simonet, DA. Gallagher, S. Waters, AJ. Lees, S. Ali, T. Boyle, RS. Weil, N. Mukadam, CR. Marshall, AJ. Noyce (London, United Kingdom)

    Objective: The East London Parkinson Disease (ELPD) project is a platform study aiming to understand the manifestations and determinants of Parkinson’s disease in a diverse…
  • 2024 International Congress

    Characterisation and longitudinal significance of subjective cognitive decline in GBA and LRRK2 Parkinson’s disease

    L. Batzu, D. Urso, S. Rota, A. Podlewska, MA. Qamar, KR. Chaudhuri (London, United Kingdom)

    Objective: To investigate the clinical characteristics and predictive value associated with subjective cognitive decline (SCD) in people with Parkinson’s disease (PD) carrying pathogenic GBA or…
  • 2024 International Congress

    Dual Frequency Stimulation of the Subthalamic Nucleus Improves Emotional State in Parkinson’s Disease

    E. Pegolo, F. Cucinotta, I. Hossain, B. Ishihara, M. Hart, E. Pereira, F. Morgante, A. Fasano, L. Ricciardi (Padova, Italy)

    Objective: To evaluate the effect on emotional states of dual frequency STN-DBS (high frequency + low frequency) as compared to high frequency or low frequency…
  • 2024 International Congress

    Shifting Tides of Caffeine: Evaluating Consumption Patterns In Parkinson’s disease Progression

    S. Bouhadoun, S. Zolfaghari, A. Delva, T. Kouchache, A. Pelletier, R. Postuma (Montréal, Canada)

    Objective: This investigation aims to explore temporal shifts in caffeine consumption throughout the Parkinson’s disease (PD) course. Background: Caffeine has been consistently associated with a…
  • 2024 International Congress

    Predicting prodromal Parkinson’s disease with a deep learning algorithm using medical and prescription data

    WW. Lee, Y. Koo, M. Kim (Seoul, Republic of Korea)

    Objective: Our previous study successfully predicted the incidence of Parkinson’s disease (PD) using only diagnostic codes unrelated to motor symptoms during prodromal periods [1]. This…
  • 2024 International Congress

    Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

    A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

    Objective: Describe the frequency of Parkinson’s disease (PD) risk factors in a European population-based study and analyze the predictive value of online survey single questions…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley